Ind-Swift Laboratories adds independent director
Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy
India's Ind-Swift Laboratories Ltd. appointed Poonam Maini an independent director of the company.
Ind-Swift develops active pharmaceutical ingredients, which are used in the manufacturing of medicines.